CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials

The Clinical Trial Service Unit at Oxford University is helping researchers worldwide run better clinical trials—faster, cleaner, and with more reliable results. This matters because poorly designed trials waste time and money, recruit too few patients, or produce shaky evidence that can mislead doctors and delay effective treatments. Many clinical experts know their disease area but lack deep expertise in trial methodology—how to design a study that will actually answer the question, how to manage data securely at scale, or how to avoid bias. The CTSU fills that gap by providing hands-on methodological guidance, particularly for trials in vascular and neoplastic diseases. If this succeeds, the public health payoff is concrete: more reliable evidence about which treatments actually reduce death and major illness. The impact is largely invisible to patients—better IT systems for large-scale trials, smarter recruitment strategies, cleaner data—but it quietly underpins every treatment decision doctors make. This is not fundamental science; it is methodological infrastructure that makes clinical research itself more trustworthy. Better trials mean fewer false leads and faster identification of treatments that save lives.